China Universal Asset Management Co., Ltd. Theravance Biopharma, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,828 shares of TBPH stock, worth $153,518. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,828
Previous 10,043
12.1%
Holding current value
$153,518
Previous $110,000
16.36%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding TBPH
# of Institutions
171Shares Held
50.5MCall Options Held
36.5KPut Options Held
147K-
Madison Avenue Partners, LP New York, NY9.51MShares$165 Million12.7% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$130 Million2.09% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$86.1 Million12.08% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$65.7 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$48 Million4.22% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $1.16B
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...